ClinicalTrials.Veeva

Menu

Magnetic Nanoparticle Sperm Separation for Teratozoospermia Male and Women Older Than 35 Years

I

Ibn Sina Hospital

Status

Completed

Conditions

Infertility

Treatments

Other: Sperm preparation for ICSI

Study type

Interventional

Funder types

Other

Identifiers

NCT03666364
IbnSina-MNP

Details and patient eligibility

About

Women over 35 years old are likely to suffer from impaired oocyte repair capacity. Teratozoospermia is a condition reflects morphological affection of sperm. These spermatozoa would add an extra burden on the oocyte after ICSI. Whether selecting mature sperm by magnetic nanoparticle protocol would provide a more competent sperm to a likely affected oocyte would improve ICSI outcomes is the question of this research.

Enrollment

1,400 patients

Sex

Female

Ages

35 to 42 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • women indicated for ICSI but with teratozoospermia

Exclusion criteria

  • Women not failing in this group

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

1,400 participants in 2 patient groups

Magnetic nanoparticle selection for teratozoospermia
Experimental group
Treatment:
Other: Sperm preparation for ICSI
Density gradient centrifugation for teratozoospermia
No Intervention group

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems